MLN Matters® Number: MM6594
Related Change Request (CR) #: 6594
Related CR Release Date: August 28, 2009
Effective Date: October 1, 2009
Related CR Transmittal #: R1805CP
Implementation Date: October 5, 2009
Provider Types Affected
Physicians, hospitals, suppliers, and other providers who submit bills to Medicare carriers, fiscal intermediaries (FIs), Medicare Administrative Contractors (MACs), and Durable Medical Equipment Medicare Administrative Contractors (DME MACs) for services provided to Medicare beneficiaries.
Provider Action Needed
This article explains updates, effective for dates of service on or after October 1, 2009, (unless otherwise specified), to the Healthcare Common Procedure Coding System (HCPCS) codes for certain drugs and biologicals. Ensure that your staffs are aware of these changes.
Background
The HCPCS code set is updated on a quarterly basis. This article describes updates for specific HCPCS codes and the October 2009 update has only one new code payable for Medicare. Effective for claims with dates of service on or after October 1, 2009, the following HCPCS code will be payable for Medicare:
- HCPCS code Q2024 with short description of Bevacizumab injection and long description of INJECTION, BEVACIZUMAB, 0.25 MG, a Type of Service Code 1 or P and a Medicare Physician Fee Schedule Data Base Status Indicator of E.
There are no deletions of HCPCS codes effective for October 1, 2009.
Additional Information
If you have questions, please contact our Provider Contact Center at our toll-free number (866) 332-7025 (Ohio and West Virginia) or (888) 828-2092 (South Carolina Part B).
The official instruction, CR 6594, issued to your Medicare carrier, FI, DME MAC and/or MAC regarding this change, may be viewed at www.cms.hhs.gov/Transmittals/downloads/R1805CP.pdf (PDF, 114 KB) on the CMS Web site.
Disclaimer
This article was prepared as a service to the public and is not intended to grant rights or impose obligations. This article may contain references or links to statutes, regulations, or other policy materials. The information provided is only intended to be a general summary. It is not intended to take the place of either the written law or regulations. We encourage readers to review the specific statutes, regulations and other interpretive materials for a full and accurate statement of their contents. CPT only copyright 2008 American Medical Association.